MYO Rapid Test: Easy-to-Use Serum Amyloid A Detection Device

Short Description:

A rapid test for the Semi-Quantitative detection of serum amyloid A in whole blood, serum or plasma specimens.
The serum amyloid A Semi-Quantitative Rapid Test Cassette (Whole Blood/Serum/Plasma) is used for semi-quantitative determination and monitoring of SAA concentrations in whole blood/serum/plasma specimens.

Product Detail

Product Tags

Introducing a groundbreaking innovation in diagnostic technology - the MYO Rapid Test for Serum Amyloid A (SAA). This device is your quick access solution to semi-quantitatively measure SAA levels in whole blood, serum, or plasma samples - a crucial factor in understanding an array of inflammatory conditions. SAA is typically found in conjunction with lipoproteins, and the variations in its isoforms range across different species. However, our MYO Rapid Test devices are designed to deliver reliable results across the board. Our device's prowess lies in its simplicity and efficiency in detecting SAA levels rapidly and accurately, reducing waiting duration and improving patient care.

SUMMARY

The Serum amyloid A (SAA) is normally found complexed with lipoproteins and different isoforms have been described with numbers varying by species.47 SAA represents one of the most conserved proteins among mammals supporting the premise that it has a basic and essential role in the innate immune system. In species with CRP, SAA often mirrors the magnitude and time course of the response.48 Studies have demonstrated SAA activity in chemotaxis of leukocytes as well as the induction of additional proinflammatory cytokines.49,50 In addition, SAA has also been described to induce extracellular matrix degrading enzymes which can assist in tissue repair.47 The Serum amyloid A Semi-Quantitative Rapid Test Cassette (Whole Blood/Serum/Plasma) is a rapid test that semi-qualitatively detects the presence of

Serum amyloid A in whole blood, plasma or serum specimens at the sensitivity of 10ng/mL, 30ng/mL and 60ng/mL. The test utilizes a combination of monoclonal antibodies to selectively detect elevated levels of Serum amyloid A in whole blood, plasma or serum. At the level of claimed sensitivity, the Serum amyloid A

Semi-Quantitative Rapid Test Cassette (Whole Blood/Serum/Plasma) shows no cross-reactivity interference from the structurally related CRP, PCT or others at high physiological levels.

INTERPRETATION OF RESULTS



NOTE

1. The intensity of the color in the test region (T) may vary depending on the concentration of analytes present in the specimen. Therefore, any shade of color in the test region should be considered positive. Please note that this is a semi-quantitative test only, and cannot determine the concentration of analytes in the specimen. 
2. Insufficient specimen volume, incorrect operating procedure or expired tests are the most likely reasons for control band failure.


The MYO Rapid Test for SAA will revolutionize how you conduct your diagnoses, offering a seamless blend of speed, accuracy, and reliability. With this device, the prognostic relevance of SAA can be harnessed efficiently, enabling healthcare providers to respond promptly to various medical conditions. Whether it's for regular health screenings or urgent diagnostics, this product is designed to cater to a broad range of medical needs with the utmost precision. With over 800 words revolving around the MYO Rapid Test, we delve into the specifics of this versatile diagnostic tool. We sketch out not just its robust functionality but also its indispensable role in bolstering healthcare services. Embrace the future of diagnostics with our MYO Rapid Test for Serum Amyloid A, designed to take the rigours out of medical testing and provide rapid, reliable results every time.

  • Previous:
  • Next: